Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001178913-09-003139
Filing Date
2009-12-24
Accepted
2009-12-24 09:16:43
Documents
1
Period of Report
2009-12-22

Document Format Files

Seq Description Document Type Size
1 a97689_ex.html 4  
1 a97689_ex.xml 4 2889
  Complete submission text file 0001178913-09-003139.txt   4864
Mailing Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 20 HAIFA L3 31905
Business Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 20 HAIFA L3 31905 972-4-850-1080
PLURISTEM THERAPEUTICS INC (Issuer) CIK: 0001158780 (see all company filings)

EIN.: 980351734 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 63 RABUTZKY STREET RAANANA L3 43220
Business Address
Aberman Zami (Reporting) CIK: 0001344740 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31392 | Film No.: 091259673